Is LakeShore Biopharma Stock a Good Investment?
LakeShore Biopharma Investment Advice | LSBPW |
- Examine LakeShore Biopharma's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research LakeShore Biopharma's leadership team and their track record. Good management can help LakeShore Biopharma navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact LakeShore Biopharma's business and its evolving consumer preferences.
- Compare LakeShore Biopharma's performance and market position to its competitors. Analyze how LakeShore Biopharma is positioned in terms of product offerings, innovation, and market share.
- Check if LakeShore Biopharma pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about LakeShore Biopharma's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in LakeShore Biopharma Co, stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if LakeShore Biopharma Co, is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine LakeShore Biopharma Stock
Researching LakeShore Biopharma's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if LakeShore Biopharma is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding LakeShore Biopharma's research are outlined below:
| LakeShore Biopharma generated a negative expected return over the last 90 days | |
| LakeShore Biopharma has high historical volatility and very poor performance | |
| LakeShore Biopharma has some characteristics of a very speculative penny stock | |
| LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
| LakeShore Biopharma Co, was previously known as YS Biopharma Co, and was traded on NASDAQ Exchange under the symbol YSBPW. | |
| The company reported the revenue of 573.42 M. Net Loss for the year was (433.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LakeShore Biopharma generates negative cash flow from operations | |
| LakeShore Biopharma has a frail financial position based on the latest SEC disclosures |
LakeShore Biopharma Quarterly Cash And Short Term Investments |
|
LakeShore Biopharma's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.30) | (0.32) | |
| Return On Capital Employed | (0.63) | (0.60) | |
| Return On Assets | (0.29) | (0.30) | |
| Return On Equity | (0.74) | (0.70) |
Determining LakeShore Biopharma's profitability involves analyzing its financial statements and using various financial metrics to determine if LakeShore Biopharma is a good buy. For example, gross profit margin measures LakeShore Biopharma's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of LakeShore Biopharma's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in LakeShore Biopharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LakeShore Biopharma Co,. Check LakeShore Biopharma's Beneish M Score to see the likelihood of LakeShore Biopharma's management manipulating its earnings.
Basic technical analysis of LakeShore Stock
As of the 21st of November, LakeShore Biopharma secures the Mean Deviation of 11.13, downside deviation of 15.98, and Risk Adjusted Performance of 0.0471. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of LakeShore Biopharma Co,, as well as the relationship between them. Please verify LakeShore Biopharma Co, coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if LakeShore Biopharma Co, is priced some-what accurately, providing market reflects its recent price of 0.04 per share. As LakeShore Biopharma Co, appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.Understand LakeShore Biopharma's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing LakeShore Biopharma's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0471 | |||
| Market Risk Adjusted Performance | 0.8001 | |||
| Mean Deviation | 11.13 | |||
| Semi Deviation | 12.69 | |||
| Downside Deviation | 15.98 | |||
| Coefficient Of Variation | 2008.84 | |||
| Standard Deviation | 18.24 | |||
| Variance | 332.83 | |||
| Information Ratio | 0.0445 | |||
| Jensen Alpha | 0.8011 | |||
| Total Risk Alpha | (1.17) | |||
| Sortino Ratio | 0.0509 | |||
| Treynor Ratio | 0.7901 | |||
| Maximum Drawdown | 103.97 | |||
| Value At Risk | (22.42) | |||
| Potential Upside | 31.95 | |||
| Downside Variance | 255.44 | |||
| Semi Variance | 161.06 | |||
| Expected Short fall | (15.57) | |||
| Skewness | 1.59 | |||
| Kurtosis | 5.61 |
| Risk Adjusted Performance | 0.0471 | |||
| Market Risk Adjusted Performance | 0.8001 | |||
| Mean Deviation | 11.13 | |||
| Semi Deviation | 12.69 | |||
| Downside Deviation | 15.98 | |||
| Coefficient Of Variation | 2008.84 | |||
| Standard Deviation | 18.24 | |||
| Variance | 332.83 | |||
| Information Ratio | 0.0445 | |||
| Jensen Alpha | 0.8011 | |||
| Total Risk Alpha | (1.17) | |||
| Sortino Ratio | 0.0509 | |||
| Treynor Ratio | 0.7901 | |||
| Maximum Drawdown | 103.97 | |||
| Value At Risk | (22.42) | |||
| Potential Upside | 31.95 | |||
| Downside Variance | 255.44 | |||
| Semi Variance | 161.06 | |||
| Expected Short fall | (15.57) | |||
| Skewness | 1.59 | |||
| Kurtosis | 5.61 |
Consider LakeShore Biopharma's intraday indicators
LakeShore Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of LakeShore Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
LakeShore Biopharma time-series forecasting models is one of many LakeShore Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary LakeShore Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
LakeShore Stock media impact
Far too much social signal, news, headlines, and media speculation about LakeShore Biopharma that are available to investors today. That information is available publicly through LakeShore media outlets and privately through word of mouth or via LakeShore internal channels. However, regardless of the origin, that massive amount of LakeShore data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of LakeShore Biopharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of LakeShore Biopharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to LakeShore Biopharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive LakeShore Biopharma alpha.
LakeShore Biopharma Corporate Management
| Yuan Liu | Head Research | Profile | |
| Zenaida MD | Chief Officer | Profile | |
| Gang Li | Head Sales | Profile | |
| Zhiyuan Ran | Head Department | Profile |
Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.